Vivos Therapeutics, Inc. (VVOS) Stock Rallying Today, Here’s the Reason
Vivos Therapeutics, Inc. (VVOS), a medical technology company, has surged 42.33% in the current market trading session. Consequently, the stock is trading at $2.32 at the time of the writing. The surge could be attributed to the announcement of an increase in Sleep Apnea Diagnostic Testing. On Tuesday, VVOS stock closed the day at $1.63 […]
Bakkt Holdings, Inc. (BKKT) Stock Rising in Premarket, Here’s the Reason
Bakkt Holdings, Inc. (BKKT), a digital asset platform, has increased by 8.59% during the premarket trading session. Consequently, BKKT stock is trading at $5.69 at the time of the writing. The stock is moving forward after the company’s selection by Nexco. On Tuesday, the stock closed the day at $5.24 after declining by 6.01% during […]
RISE Education Cayman Ltd. (REDU) Stock Sliding in Aftermarket, Here’s the Reason
RISE Education Cayman Ltd. (REDU), a company that provides junior English language training services through its subsidiaries, has declined 4.50% during aftermarket trading session and consequently is trading at $0.50 at the time of the writing. The decline could be attributed to the receipt of the NASDAQ notice for non-compliance. On Tuesday, REDU stock closed […]
DatChat, Inc. (DATS) Stock had a Hefty Tuesday, Here’s Why
DatChat, Inc. (DATS), a communication software company, has declined by 4.80% during the aftermarket trading session. Consequently, the stock is trading at $3.17 at the time of the writing. The decline could be attributed to the profit-taking factor after the stock rocketed by 38.75% during Tuesday’s regular trading session and closed the day at $3.33. […]
Broadcom Inc. (AVGO) Stock on a Rally in Aftermarket, Here’s the Reason
Broadcom Inc. (AVGO), a company that designs, develops, and supplies various semiconductor devices, has soared 12.59% in aftermarket trading session and consequently is trading at $671.451 at the time of the writing. The bullish behavior could be seen due to the approaching earnings release date. During Monday’s regular trading session, the stock slightly declined by […]
VYNE Therapeutics Inc. (VYNE) had a Bearish Spell, Here’s Why
VYNE Therapeutics Inc. (VYNE), a pharmaceutical company, has surged 7.7% in aftermarket trading session and consequently is trading at $0.74 at the time of the writing. On Monday, VYNE closed the day at $0.6871 after plummeting by 12.53% during regular trading hours. The massive slide was attributable to the divestment of topical minocycline assets. Why […]
ION Geophysical Corp. (IO) Stock on a Rise in Aftermarket, Here’s the Reason
ION Geophysical Corp. (IO), a company that provides data-driven decision-making to offshore energy, ports, and defense industries worldwide, has surged 5.88% in aftermarket trading session. As a result, IO stock is trading at $0.9 at the time of the writing. The surge has come as the company announced forbearance and amendment related to its revolving […]
China SXT Pharmaceuticals, Inc. (SXTC) Stock in Decline Despite no Obvious Reason
China SXT Pharmaceuticals, Inc. (SXTC), a pharmaceutical company, has declined by 6.79% in aftermarket trading session. As a result, the stock is trading at $0.501 at the time of the writing. On Friday, the stock closed the day at $0.5375 after declining 0.44% during the regular trading session. The last news from the company was […]
Perella Weinberg Partners (PWP) Stock Faltering in Premarket, Here’s Why
Perella Weinberg Partners (PWP), an independent advisory firm, has declined 6.40% in premarket trading session and consequently is trading at $12 at the time of the writing. On Thursday, PWP closed the day at $12.82 after declining 1.08% during regular trading hours. The consistent decline could potentially be associated with the commencement of the public […]
Salarius Pharmaceuticals, Inc. (SLRX) Stock Declining Despite No Negative News
Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biotechnology company, has plunged 7.77% in the premarket trading session. As a result, SLRX stock is trading at $0.45 at the time of the writing. The slide has come despite a positive development for the company in the form of expansion in the oncology pipeline. On Thursday, the stock […]
